Question 1

What is AMLODIPINE AND ATORVASTATIN used for?

Accepted Answer

AMLODIPINE AND ATORVASTATIN (brand name Amlodipine and Atorvastatin) is a Other indicated for to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, including, as appropriate.

Question 2

How does AMLODIPINE AND ATORVASTATIN work?

Accepted Answer

AMLODIPINE AND ATORVASTATIN works through the following mechanism: 12.1 Mechanism of Action Amlodipine and atorvastatin tablets are a combination of two drugs, a dihydropyridine calcium channel blocker (amlodipine) and an HMG-CoA reductase inhibitor (atorvastatin). The amlodipine component of amlodipine and atorvastatin tablets inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle. The atorvastatin component of amlodipine and atorvastatin tablets is a selective, competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme that converts 3-hydroxy-3-methylglutaryl-coenzyme A to mevalonate, a precursor of sterols, including cholesterol. Amlodipine Amlodipine binds to both dihydropyridine and nondihydropyridine binding sites. The contractile processes of cardiac muscle and vascular smooth muscle are dependent upon the movement of extracellular calcium ions into these cells through specific ion channels. Amlodipine inhibits calcium ion influx across cell membranes selectively, with a greater effect on vasc.

Question 3

What are the most common side effects of AMLODIPINE AND ATORVASTATIN?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for AMLODIPINE AND ATORVASTATIN. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is AMLODIPINE AND ATORVASTATIN the same as Amlodipine and Atorvastatin?

Accepted Answer

Amlodipine and Atorvastatin is a brand name for AMLODIPINE AND ATORVASTATIN. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

AMLODIPINE AND ATORVASTATIN

Mechanism of Action

Indications

FDA Warnings

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations